British company fined for falling foul of Cancer Act

BMJ 1994; 308 doi: 10.1136/bmj.308.6922.158 (Published 15 January 1994)
Cite this as: BMJ 1994;308:158.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. O Dyer

    A company in Britain that sells herbal medicines was convicted last week under the Cancer Act 1939 of making illegal claims about one of its products. Eladon Ltd, which operates from Bangor, north Wales, was fined pounds sterling 500 and ordered to pay pounds sterling 3500 costs after being found guilty by magistrates in Whitminster of contravening the act in its promotional material.

    Eladon's product, Elagen, is an extract of Siberian eleutherococcus, a root widely used by doctors in Russia, where it is credited with curing a wide range of ailments. The claims about its efficacy were sent to potential customers who had …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL